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Clostridium botulinum type C and D strains recently have been found to produce PLC on egg yolk 
agar plates.  To characterize the gene,  enzymatic and biological activities of C. botulinum PLCs 
(Cb-PLCs),  the cb-plc genes from 8 strains were sequenced,  and 1 representative gene was cloned and 
expressed as a recombinant protein.  The enzymatic and hemolytic activities of the recombinant 
Cb-PLC were measured and compared with those of the Clostridium perfringens alpha-toxin.  Each of 
the eight cb-plc genes encoded a 399 amino acid residue protein preceded by a 27 residue signal peptide.  
The protein consists of 2 domains,  the N- and C-domains,  and the overall amino acid sequence identity 
between Cb-PLC and alpha-toxin was greater than 50ｵ,  suggesting that Cb-PLC is homologous to the 
alpha-toxin.  The key residues in the N-domain were conserved,  whereas those in the C-domain which 
are important in membrane interaction were diﬀerent than in the alpha-toxin.  As expected,  Cb-PLC 
could hydrolyze egg yolk phospholipid,  p-nitrophenylphosphorylcholine,  and sphingomyelin,  and also 
exhibited hemolytic activity; however,  its activities were about 4- to over 200-fold lower than those of 
alpha-toxin.  Although Cb-PLC showed weak enzymatic and biological activities,  it is speculated that 
Cb-PLC might play a role in the pathogenicity of botulism or for bacterial survival.
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lostridium botulinum,  a gram-positive spore-form-
ing anaerobic bacterium,  can be classiﬁed into 
seven distinct types (A-G) based on the immunological 
speciﬁcity of the neurotoxin (NTX) [1].  NTX is one 
of the most potent toxins among all bacterial,  animal,  
and plant toxins as well as chemical compounds,  and 
is considered as the essential virulence factor giving 
rise to food-borne botulism.  C. botulinum types C,  D,  
and E also produce hemolysin,  named botulinolysin 
[2].  Furthermore,  types C and D produce C2 toxin 
and C3 exoenzyme in addition to these toxins.  C2 
toxin exhibits an ADP-ribosyltransferase activity by 
which it ADP-ribosylates non-muscular G-actin,  lead-
ing to a disruption of actin function,  whereas the C3 
C
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exoenzyme is a Rho-GTPase ADP-ribosylating enzyme 
[3,  4].  It has been reported that C. botulinum is a 
phospholipase C non-producing bacterium.  Oguma et 
al.,  however,  found that the colonies of many type C 
and D strains,  cultivated on GAM-egg yolk agar 
plates,  demonstrated opacity around their colonies 
(Lecito-vitellin- or Nagler-reaction),  suggesting that 
these cultures produce phospholipase C (PLC) [5].
　 Many studies have been conducted to characterize 
bacterial PLCs,  and have shown that not all of them 
are toxic.  C. perfringens alpha-toxin (alpha-toxin),  C. 
absonum PLC (absonum-PLC),  and C. novyi PLC 
(novyi-PLC) are toxic PLCs,  but alpha-toxin is the 
most toxic among them.  On the other hand,  other 
clostridial PLCs such as C. bifermentans PLC (bifer-
mentans-PLC) and C. sordellii PLC (sordellii-PLC) 
are considered to be of low toxicity compared with 
alpha-toxin and absonum-PLC [6-10].  Until now,  
only alpha-toxin has been widely investigated.  Alpha-
toxin,  which is a zinc metallophospholipase C,  is 
known as the key virulence factor in gas gangrene.  It 
has PLC,  sphingomyelinase (SMase),  hemolytic,  and 
myotoxic activities,  and is toxic to humans and ani-
mals [7,  8].  The mature alpha-toxin is formed by 
370 amino acid residues,  and consists of 2 domains,  
the N- and C-domains [11].  The alpha helical 
N-domain is a catalytic domain containing the active 
site cleft that catalyzes phospholipid membrane hydro-
lysis with the preferred substrates phosphatidylcho-
line and sphingomyelin,  which are the major compo-
nents of the outer leaﬂet of the eukaryotic cell 
membrane,  while the beta sandwich C-domain func-
tions as a membrane-binding domain [7,  11,  12].  The 
C-domain is found to be an analog to the C2-like 
domain of the eukaryotic phospholipid-binding domain;  
therefore,  it is thought that the C-domain plays an 
important role in membrane phospholipid recognition 
in a calcium-dependent manner [11].  The PLCs pro-
duced by the above-mentioned clostridia also have 2 
domains like the alpha-toxin,  although their amino acid 
sequences are somewhat diﬀerent [6-10].  In con-
trast,  the Bacillus cereus PLC (Bc-PLC),  which is a 
non-toxic PLC,  has only the N-domain [13].
　 Whether 1) C. botulinum type C and D cultures 
produce PLCs,  and 2) these PLCs (Cb-PLCs) pos-
sess toxic properties,  has not yet been investigated.  
Therefore,  we sequenced the predicted Cb-PLC 
genes (cb-plc) from eight strains of types C and D.  
Since the amino acid identities among these strains 
were high,  only one representative gene,  i.e.,  the C. 
botulinum type D strain 1873 (D-1873) cb-plc,  was 
cloned,  and was used to construct the expression vec-
tor for the recombinant Cb-PLC (rCb-PLC).  The 
primary structure,  and the enzymatic and hemolytic 
activities of the rCb-PLC,  as well as the PLC activ-
ity of the type C and D cultures,  were analyzed and 
compared with those of alpha-toxin.
Materials and Methods
　 Bacterial strains, preparation of DNA, and 
sequence analysis. DNA was prepared from the 
C. botulinum type C and D strains C-Stockholm (C-St),  
C-468,  C-203,  C-CB19,  C-6813,  C-D6F,  D-1873,  
and D-CB16,  which demonstrated opacity around their 
colonies on egg yolk agar plates.  These bacteria were 
cultivated overnight under an anaerobic condition at 
37℃.  The total DNAs of all eight strains were iso-
lated using a DNeasy Blood & Tissue Kit (Qiagen,  
Hilden,  Germany) according to the manufacturerʼs 
protocol.  To determine the nucleotide sequences of the 
internal region of cb-plc,  the cb-plc genes were ampli-
ﬁed with speciﬁc primers that recognize only the 
conserved region among clostridial PLC,  PLC.IPCR-7f 
and PLC.IPCR-7r (Table 1,  Fig.  1).  Puriﬁed DNAs 
(1µg) were digested separately by overnight incubation 
with MboI,  NdeI,  PstI,  PvuII,  and XbaI at tempera-
tures recommended by the manufacturer.  For circu-
larization,  each restriction fragment was subse-
quently self-ligated with a T4 DNA ligase (Toyobo,  
Osaka,  Japan).  Furthermore,  the upstream and down-
stream ﬂanking regions of unknown sequences were 
determined by a combination of inverse PCR (IPCR) 
and primer-walking methods using custom primers with 
sequences based on primer-walking analysis results 
(Table 1,  Fig.  1).  The PCR products were then 
sequenced with a Big Dye terminator v3.1 cycle 
sequencing kit (Applied Biosystems,  Foster City,  CA,  
USA),  and the dye-labeled extension products were 
analyzed with an ABI Prism 3130×1 DNA genetic 
analyzer (Applied Biosystems).  The sequences were 
deposited in GenBank with the following Accession 
Numbers: AB699603,  AB699604,  AB699605,  
AB699606,  AB699607,  AB699608,  AB699609,  
AB699612.
　 Construction of recombinant Cb-PLC (rCb-
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PLC) and recombinant alpha-toxin (rAlpha-
toxin) expression systems. The cb-plc of C. botu-
linum D-1873 without a signal peptide sequence was 
ampliﬁed by PCR using genomic DNA as a template 
with the set of PCR primers CPLC(EcoR)-1f 
GGAATTCCTGGGATGGAAAACCTGATGGTACA 
and DPLC(Xho)-1r CCGCTCGAGCGGTTATTTAT 
TATTTATATAGAATGTTTTGTTATC.  The ampli-
ﬁed PCR products were digested with EcoRI and XhoI,  
and cloned into the pGEX-6P-3 plasmid vector (GE 
Healthcare,  Piscataway,  NJ).  The resulting pGEX-
6P-3 plasmid was then transformed into Escherichia coli 
DH5α cells (Invitrogen,  Carlsbad,  CA,  USA).  
Transformants were selected on LB agar plates con-
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Table 1　 PCR primer sets for amplifying cb-plc
No. Primer name Sequence (5ʼ→3ʼ) Position (bp)＊ Aim
1. PLC.IPCR-1f GTTCTACTTATCCAGATTATGATCC 232 to 256 IPCR and walking primer
2. PLC.IPCR-2f GCAACATGGCTTTTAGGACAAGG 429 to 451 IPCR and walking primer
3. PLC.IPCR-3f CAGCAGGAACTAATAGTGTAAAGG 577 to 600 IPCR and walking primer
4. PLC.IPCR-4f AGTATCAGGAACAATAAATACAACTG 806 to 831 IPCR and walking primer
5. PLC.IPCR-5f TTTCAAGTACATCACCTAAAG －454 to －474 Walking primer
6. PLC.IPCR-6f CATACAAAAATGTTAACAATAAG －224 to －253 Walking primer
7. PLC.IPCR-7f TAGTGCAGTATTATCATTCAC 32 to 52 IPCR,  walking primer,  and internal sequence
8. PLC.IPCR-8f ATGAGTGGTTTGGAGATAAC 1153 to 1172 IPCR and walking primer
9. PLC.IPCR-13f CATTGTAACTTCTTTTGCATC 1782 to 1802 Walking primer
10. PLC.IPCR-14f GATCCAAAATTATTAAGGTACATCCC －1701 to －1726 Walking primer
11. PLC.IPCR-15f TATTTTAATGTTTGGACTTCC 2079 to 2099 Walking primer
12. PLC.IPCR-16f CTGCAGCTGGTAAGAGAACTAAG －2842 to －2864 Walking primer
13. PLC.IPCR-17f AAGACTTCTTATTAGGAGAAG －2511 to －2531 Walking primer
14. PLC.IPCR-18f TCATCACGATCATGATCATG －2155 to －2174 Walking primer
15. PLC.IPCR-19f TTATCTATTGCAGGAGATGC 1462 to 1481 Walking primer
16. PLC.IPCR-1r TTCTTTTACACTTAAAGGTGATGTAC 163 to 188 IPCR and walking primer
17. PLC.IPCR-2r TTGACTAATTGCATATGATAGATACC 331 to 356 IPCR and walking primer
18. PLC.IPCR-3r CCTTTACACTATTAGTTCCTGCTG 577 to 600 IPCR and walking primer
19. PLC.IPCR-4r TAGCTGCTATTTCCCAATCTTTCC 721 to 744 IPCR and walking primer
20. PLC.IPCR-5r ATCCTATATTTCCATCTTATTC －83 to －104 IPCR and walking primer
21. PLC.IPCR-6r CTACAAGTTCTATTTAAACATAC －313 to －335 Walking primer
22. PLC.IPCR-7r TTAATTCTATAACTATCTTCTTG 987 to 1009 IPCR,  walking primer,  and internal sequence
23. PLC.IPCR-8r TATTATAGCAAGTGCAGCTC 2102 to 2121 Walking primer
24. PLC.IPCR-14r GGAGGATAATATATGTGATG 1945 to 1964 Walking primer
25. PLC.IPCR-16r AAAAAGGACAACTCTATTCC －2341 to －2360 Walking primer
26. PLC.IPCR-17r AATTACCCTTAGGTTCTTTAG －2535 to －2555 Walking primer
27. PLC.IPCR-18r TTCCTATCTTCTGTAATGTAC 1350 to 1370 IPCR and walking primer
＊Position 0 (zero) refers to the ﬁrst nucleotide of the ATG start codon of cb-plc.
IPCR,  inverse PCR.
taining 50µg/ml ampicillin,  and plasmid DNA was 
extracted from the E. coli cell cultures.  Sequencing 
reactions were performed with vector-speciﬁc primers.  
The construction of recombinant alpha-toxin (rAlpha-
toxin) was conducted as reported by Nagahama et al. 
[14].  Brieﬂy,  the 1.3-kb SspIHindIII fragment con-
taining the alpha-toxin gene was subcloned from pUAT 
into the pHY300PLK (E. coli-Bacillus subtilis shuttle 
vector) SmaI site and transformed into B. subtilis 
ISW1214.
　 Expression and puriﬁcation of rCb-PLC and 
rAlpha-toxin. rCb-PLC was expressed as a GST 
fusion protein after adding isopropyl-β-D(-) thiogalac-
topyranoside (IPTG) (Wako,  Osaka,  Japan) to a ﬁnal 
concentration of 0.1mM to E. coli BL21-CodonPlus® 
(DE3)-RIL (Stratagene,  La Jolla,  CA,  USA) trans-
formant cell cultures.  Cells were harvested by cen-
trifugation at 8,000×g,  4℃,  for 20min,  and then 
resuspended in phosphate-buﬀered saline (pH7.3) 
(PBS).  The cells were sonicated on ice and centri-
fuged at 24,000×g for 30min at 4℃,  and then the 
supernatant was collected and applied to Glutathione 
Sepharose 4B aﬃnity chromatography (GE Healthcare) 
at a ﬂow rate of 0.5ml/min.  After washing the column 
with PBS,  the protein was eluted with 10mM reduced 
glutathione (Wako) in 50mM Tris-HCl (pH8.0).  The 
eluted fractions were pooled and dialyzed against 
cleavage buﬀer (50mM Tris-HCl,  pH7.5,  containing 
150mM NaCl,  and 1mM DTT without EDTA).  After 
dialysis,  GST was removed by treatment with 
PreScission Protease (GE Healthcare).  The solution 
was loaded onto the aﬃnity chromatography column,  
and the pass-through fractions containing rCb-PLC 
were collected,  dialyzed against 10mM phosphate 
buﬀer (pH7.5),  and applied to a MonoQ HR5/5 anion-
exchange chromatography column (GE Healthcare) 
equilibrated with the same buﬀer.  The proteins were 
eluted with a sodium chloride gradient (0-1M) in 
50mM phosphate buﬀer (pH7.5).  The eluted proteins 
were dialyzed against 0.02M Tris-HCl (pH7.5).  The 
expression and puriﬁcation of rAlpha-toxin was per-
formed as described in a previous study [14].  Brieﬂy,  
transformants were cultured in LB broth at 37℃ for 
12h.  The culture supernatant was collected by cen-
trifugation,  precipitated by ammonium sulfate,  and 
incubated at 4℃ overnight.  The precipitate was col-
lected by centrifugation and was dissolved in 20mM 
Tris-HCl buﬀer (pH7.5).  The ammonium sulfate frac-
tion was applied to a Cu-chelate Sepharose aﬃnity 
column.  Fractions containing rAlpha-toxin were dia-
lyzed against 20mM bis Tris- HCl buﬀer (pH6.2) at 
4℃ for 12h and were then loaded onto a Mono-Q 
HR5/5 column (Pharmacia,  Uppsala,  Sweden) pree-
quilibrated with 20mM bis Tris-HCl buﬀer (pH6.2).  
The recombinant Alpha-toxin was eluted with a sodium 
chloride gradient (0-0.5M) in 20mM bis Tris-HCl 
(pH6.2).  The protein concentration was determined by 
the Lowry method using bovine serum albumin as a 
standard.
　 Detection of enzymatic and biological activi-
ties. To determine the PLC activity on solid 
medium,  C. botulinum C-St,  D-1873,  and C. perfrin-
gens NCTC 8237 were inoculated on GAM-egg yolk 
agar plates,  and incubated under appropriate condi-
tions as reported previously [5].  The activity was 
observed as clearly marked opacity spreading from the 
colony edge.
　 To examine PLC activity using 20ｵ egg yolk solu-
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Fig. 1　 Schematic representation of the cb-plc sequencing map.  The details of the primer sequences are described in Table 1.  
Arrowheads represent the primer positions and their directions.  The names of primer are labeled as numbers,  and “f” and “r” indicate for-
ward and reverse primers.  Abbreviations of the restriction enzymes: M,  MboI; N,  NdeI; Ps,  PstI; Pv,  PvuII; X,  XbaI.  Primers PLC.
IPCR-7f and PLC.IPCR-7r were used to amplify the internal sequence of cb-plc.
tion,  the solution was prepared as described else-
where [15] with slight modiﬁcations.  One freshly 
obtained egg yolk diluted in 500ml of 0.02M Tris-
HCl (pH7.5) containing 0.9ｵ NaCl (TBS) was mixed 
with 20g kaolin.  The egg yolk solution was collected 
from the supernatant after centrifugation at 11,000×
g for 20min at 4℃.
　 C. botulinum C-St,  D-1873,  and C. perfringens 
NCTC 8237 were cultivated in LYG medium [5] 
under an anaerobic condition at 37℃ for 16h.  Ten-
fold serially diluted ﬁltered-bacterial cultures (100µl) 
were mixed with 200µl of egg yolk solution,  and were 
incubated at 37℃ for 30min.  To measure the egg yolk 
hydrolysis activity of the recombinant proteins,  two-
fold serially diluted rCb-PLC and rAlpha-toxin (pro-
tein concentration 0.04-10µg/ml) were pre-incubated 
with CoCl2 (ﬁnal concentration: 1mM) at 37℃ for 
20min,  and diluted with TBS containing 0.25ｵ gela-
tin (G-TBS) to a ﬁnal volume of 100µl.  Egg yolk 
solution (200µl) was then added into the protein solu-
tion,  and the incubation was continued at 37℃ for 
30min.  All egg yolk hydrolysis assay measurements 
were made at 655nm.  The concentration of protein 
which showed 50ｵ turbidity was calculated.  The 
p-NPPC assay was conducted as described previously 
[16].  Recombinant proteins were mixed with 20mM 
p-NPPC,  0.25M Tris-HCl (pH7.2),  60ｵ w/v sorbi-
tol,  and 0.5M CoCl2,  and then incubated at 35℃ for 
90min.  The amount of p-nitrophenol product was 
calculated by using a molar extinction coeﬃcient of 
1.54×104.
　 The SMase activity of the recombinant protein was 
examined by incubating rPLCs (1.0µg/ml) with 1.0mM 
sphingomyelin from bovine brain (Nacalai Tesque,  
Kyoto,  Japan) solubilized in 1.0ｵ sodium cholate 
containing CaCl2 (ﬁnal concentration: 0.5mM),  and 
incubated at 37℃ for 3h.  The turbidity of the reac-
tion mixture was measured at 620nm.  The standard 
curves are described by the turbidity of ceramides 
from bovine brain (Avanti Polar Lipids,  Alabaster,  
AL,  USA).
　 The hemolysis assay was performed as described 
elsewhere [17] with some modiﬁcations.  Two-fold 
serially diluted recombinant proteins (the concentra-
tions of rAlpha-toxin were 0.01-0.5µg/ml,  while those 
of rCb-PLC were 0.4-50µg/ml) in G-TBS (100µl) 
were pre-incubated with CoCl2 (ﬁnal concentration:  
4mM) at 37℃ for 20min.  The solution was incubated 
with 1ｵ washed rabbit erythrocytes (100µl) in TBS 
containing CaCl2 (ﬁnal concentration: 3mM) and G-TBS 
to give a total volume of 300µl,  at 37℃ for 30min,  
and subsequently chilled at 4℃ for 10min.  Unlysed 
cells were removed by centrifugation at 1,750×g,  
4℃ for 5min,  and the absorbance of the supernatant 
was measured at 570nm.  The concentration of protein 
which showed 50ｵ hemolytic activity was calculated.  
All the assays above were performed in triplicate.
Results
　 Cb-PLC nucleotide sequence and deduced 
amino acid sequence. The predicted cb-plc genes 
were successfully identiﬁed in all eight strains of 
types C and D employed.  Each of these genes con-
sisted of 1,200 nucleotides and encoded a 399 amino 
acid residues protein.  The amino acid sequence iden-
tity among these strains was over 98ｵ; therefore,  
we used C. botulinum D-1873 as the representative of 
all strains employed to construct the expression vector 
of rCb-PLC.  A previous study reported that the C. 
perfringens alpha-toxin is post-translationally processed 
into a mature protein [18].  Therefore,  the deduced 
amino acid sequence of the Cb-PLC was analyzed 
using the SignalP (version 3.0) program [19],  which 
predicted that the N-domain of the precursor protein 
had characteristics of a signal peptide with a probable 
cleavage site between Ala27 and Trp28 (Fig.  2).  The 
mature Cb-PLC had 372 amino acid residues with a 
calculated molecular mass of ～43kDa.  The alpha-
toxin is known to consist of 2 domains,  the N- and 
C-domains,  which contain the active site and mem-
brane binding site,  respectively [11].  Multiple 
sequence alignments of Cb-PLC and alpha-toxin sug-
gested that Cb-PLC was also composed of an 
N-domain and a C-domain,  with an overall amino acid 
sequence identity of 52.6ｵ.  The amino acid identity 
of the N-domain between Cb-PLC and alpha-toxin was 
60.8ｵ.  The identities of the N-domains among Cb-,  
bifermentans-,  sordellii-,  novyi-,  and absonum-PLCs 
ranged from 55.9ｵ to 63.7ｵ (Table 2).  However,  the 
identity of the N-domain between Cb-PLC and the non-
toxic Bc-PLC was low (less than 25ｵ).  Between 
Cb-PLC and alpha-toxin,  the amino acid identity of the 
C-domain was 44.9ｵ,  and the identity between Cb-PLC 
and other clostridial PLCs was 43.5-49.5ｵ (Table 2).
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　 Construction and expression of rCb-PLC and 
rAlpha-toxin. The C. botulinum type D-1873 PLC 
gene (cb-plc) was cloned and expressed as a represen-
tative of the PLCs produced by C. botulinum types C 
and D,  and alpha-toxin was also expressed as a recom-
binant protein as described in the Materials and 
Methods.  The puriﬁed recombinant proteins were 
analyzed by SDS-PAGE in the presence of 2-mercap-
toethanol (Fig.  3).  The results showed that the 
molecular masses of proteins were about 43kDa and 
both proteins seemed to be homogenous.
　 The enzymatic and biological activities of 
Cb-PLC. C. perfringens NCTC 8237,  C. botulinum 
C-St,  and D-1873 produced opacity around their colo-
nies on GAM-egg yolk agar plates (Fig.  4A).  Moreover,  
the serially diluted cultures of C-St and D-1873 suc-
cessfully hydrolyzed egg yolk phospholipid in solution,  
though their titers were signiﬁcantly lower than that 
of C. perfringens (data not shown).  The rCb-PLC and 
rAlpha-toxin also produced opacity on egg yolk agar 
plates (Fig.  4B),  although a higher concentration of 
rCb-PLC (50µg/ml) was required to produce opacity 
similar to that induced by rAlpha-toxin (5µg/ml).
　 The speciﬁc activities of rCb-PLC were then 
quantitatively compared with those of rAlpha-toxin.  
First,  the eﬀects of CoCl2,  MgCl2,  CaCl2,  and ZnCl2 
on the enzymatic and biological activities of the 
recombinant protein were conducted.  We found that 
the egg yolk phospholipid hydrolysis,  p-NPPC hydro-
lysis,  and hemolytic activities were most activated by 
CoCl2,  while SMase activity was activated by CaCl2.  
As summarized in Table 3,  the egg yolk phospholipid 
hydrolysis and p-NPPC hydrolysis activities of rCb-
PLC were 23.3ｵ and 1.6ｵ those of rAlpha-toxin,  
respectively.  Furthermore,  the SMase and hemolytic 
15Characteristics of botulinum PLCFebruary 2013
Table 2　 Comparison of amino acid sequences of Cb-PLC,  alpha-toxin,  novyi-,  absonum-,  sordellii-,  and bifermentans-PLCsa
Phospholipase C
% Identity (N-domain/ C-domain)
Cb-PLC alpha-toxin novyi-PLC absonum-PLC sordellii-PLC bifermentans-PLC
Cb-PLC 52.6
(60.8/44.9)
55.5
(60.4/49.5)
56.9
(63.7/47.7)
51.5
(55.9/47.2)
50.4
(56.3/43.5)
alpha-toxin 60.6
(69.4/52.4)
58.3
(64.1/56.2)
51.4
(58.3/45.8)
50.9
(58/46.7)
novyi-PLC 61.3
(69.4/53.3)
54.8
(59.6/53.3)
52
(59.6/48.6)
absonum-PLC 52.6
(58.8/46.7)
52.3
(59.6/42.5)
sordellii-PLC 76
(82/70.1)
bifermentans-PLC
aThe data for Cb-PLC is from this study.  The data for the other clostridial PLC sequences are registered at the GenBank database under 
the following accession numbers: alpha-toxin,  accession no.  ABA64093 ; novyi-PLC, no.  BAA06851 ; absonum-PLC,  no.  
AY159815; sordellii-PLC,  no.  BAB83263; and bifermentans-PLC,  no.  BAB83265.
250
150
100
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50
37
25
20
10
kDa M 1 2
Fig. 3　 SDS-PAGE analysis of puriﬁed rPLC.  Electrophoresis 
was performed on a 12.5% polyacrylamide gel in the presence of 
2-mercaptoethanol.  Lane 1: rCb-PLC; Lane 2: rAlpha-toxin.  M:  
standard molecular mass markers (kDa).  The molecular mass of 
either rCb-PLC or rAlpha-toxin is approximately 43kDa.
activities of rCb-PLC were approximately 10- and 
200-fold lower than those of rAlpha-toxin.
Discussion
　 In the present study we successfully cloned the cb-
plc gene,  constructed and puriﬁed rCb-PLC,  and 
determined the enzymatic and hemolytic activities of 
rCb-PLC.  The multiple sequence alignment between 
Cb-PLC and alpha-toxin showed that Cb-PLC is a 
homolog of the alpha-toxin and consists of 2 domains,  
the N- and C-domains.  The N-domain is a catalytic 
domain containing the active site cleft of the PLC 
protein,  within which 3 zinc cations are coordinated.  
Several amino acid residues in the N-domain that are 
important for 1) zinc binding coordination of Zinc 1 
(Trp1,  His11,  Asp130),  Zinc 2 (His136,  His148,  
Glu152),  and Zinc 3 (His68,  His126,  Asp56,  
Asp130),  2) catalytic activity (Asp56 and Thr74) and 
3) maintaining the conformational structure of PLC 
(Asp130 and Thr272),  were found to be conserved in 
Cb-PLC compared with those of alpha-toxin and other 
clostridial PLCs [11,  14,  20-23]; thus,  it is specu-
lated that Cb-PLC has an N-domain structure that 
corresponds to a zinc metallophospholipase C.  In 
contrast,  compared with the alpha-toxin,  several 
important residues in the C-domain of Cb-PLC were 
not conserved.  Residues Asp269,  Tyr275,  Tyr331,  
and Phe334 in alpha-toxin [24,  25],  which lie on the 
protein surface and have been proposed to be involved 
in membrane binding,  were found to be replaced by 
Lys268,  Ser 275,  Gly330,  and Val333 in Cb-PLC,  
respectively (Fig.  2).
　 We conﬁrmed that C. botulinum type C and D pro-
duced PLC.  We measured the activities of rCb-PLC 
and compared them with those of rAlpha-toxin.  In the 
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Table 3　 Comparison of the enzymatic and biological activities of rCb-PLC and rAlpha-toxin
Phospholipase C
Egg 
yolk-phospholipid 
hydrolysis 
(ng/300µl)
(% activity relative 
to alpha-toxin)
p-NPPC hydrolysis
(nmol/mg/min)
(% activity relative to 
alpha-toxin)a
Sphingomyelinase
(U/mg/min)
(% activity relative 
to alpha toxin)a
Hemolysis
(ng/300µl)
(% activity 
relative to 
alpha-toxin)
rCb-PLC 490.2 (23.3) 3.75±0.19 (1.6) 0.24±0.09 (9.4) 1,719 (0.5)
rAlpha-toxin 114.4 (100) 235.21±4.02 (100) 2.55±0.25 (100) 8.7 (100)
aData are the mean values ± SD (n＝3).
A
(1) (2) (3)
B
(1) (2)
Fig. 4　 A,  The PLC reaction of C. botulinum C-St (1),  D-1873 (2),  and C. perfringens NCTC 8237 (3) on GAM-egg yolk agar plates.  
The reaction resulted in opacity around the colonies; B,  The PLC activity of the rCb-PLC (1) and rAlpha-toxin (2) (incubation time: 3h) 
was represented as the opacity observed on GAM-egg yolk agar plates (concentration of rCb-PLC: 50µg/ml; concentration of rAlpha-
toxin: 5µg/ml).  These ﬁgures conﬁrm that the C. botulinum type C and D strains produce PLC.
present study,  we used a GST-fusion protein in pre-
paring rCb-PLC,  whereas for rAlpha-toxin we used 
an E.coli-B.subtilis expression system.  Although we 
used a GST-fusion protein for rCb-PLC preparation,  
we successfully removed the tag from the recombinant 
protein,  thereby avoiding any GST-tag-interference in 
the recombinant protein activities.  In addition,  we 
successfully measured the enzymatic and biological 
activities of rCb-PLC,  although these activities were 
somewhat weaker than those of the alpha-toxin.  The 
speciﬁc activities of rCb-PLC reported in the present 
study seemed to be comparable to those of bifermen-
tans- and sordellii-PLCs [9].  In that study,  
Karasawa et al. reported both bifermentans- and sor-
dellii-PLCs that were expressed as His-tag recombi-
nant proteins showed weaker enzymatic and hemolytic 
activities compared with those of alpha-toxin.
　 As described above,  the key residues of the 
N-domain (catalytic domain) in Cb-PLC and other 
clostridial PLCs were fully conserved,  as in the 
alpha-toxin.  However,  4 key residues in the C-domain 
of Cb-PLC that are important for membrane binding 
were not conserved,  just as they were not conserved 
in bifermentans- and sordellii-PLCs [9].  In contrast,  
absonum-PLC,  a toxic PLC,  showed only 2 muta-
tions in 4 four residues,  Leu331 and Ala334 [10].  
Although we have not yet performed experiments for 
the enzymatic and binding activities using the isolated 
N-domain or C-domain,  or the binding experiment with 
whole rCb-PLC,  we speculate that the relatively low 
enzymatic activity of Cb-PLC may be due to the dif-
ferences of amino acid residues,  except the important 
ones,  in the N-domain.  Since the C-domain has struc-
tural analogy with the C2-like domain of eukaryotic 
phospholipid-binding proteins,  which is involved in 
membrane phospholipid interaction,  it is thought that 
the quite low hemolytic activity may be inﬂuenced by 
low cell binding ability through the C-domain,  which 
is caused by diﬀerences of amino acid residues,  
including the key residues.
　 Alpha-toxin is considered to be the important viru-
lence factor in causing gas gangrene.  As previously 
reported,  a large amount of alpha-toxin can directly 
cause membrane hydrolysis [26].  In the case of types 
C and D of C. botulinum,  these bacteria rarely cause 
botulism in humans,  but are known to be responsible 
for big outbreaks in wild birds and domestic animals 
such as cattle,  even though they are much harder to 
grow in media than other types of botulinum organ-
isms.  In our preliminary experiments,  large amounts 
of type C and D NTXs (more than 106 LD50 in total) 
were needed to kill the cattle,  when they were orally 
administered.  As mentioned above,  the amount of 
rCb-PLC required for complete hemolysis was high 
compared with the amount of alpha-toxin required,  but 
it was still about 7.5µg protein/300µl,  a volume that 
might be produced during the cell growth of types C 
and D in the animal intestine or in the environment.  
Therefore,  we speculate that organisms may produce 
enough Cb-PLC to disrupt the intestinal cell mem-
branes to facilitate the passage of NTX across the 
intestinal barrier into the blood circulation.  In addi-
tion,  since C. botulinum types C and D also produce 
botulinolysin (Bly),  which is a cytolytic toxin,  it is 
suggested that Cb-PLC and Bly might have a syner-
gistic eﬀect in membrane disruption.  It is also consid-
ered that Cb-PLC might participate indirectly in C. 
botulinum pathogenicity by obtaining the nutrients 
needed for bacterial growth and multiplication from 
lysed host cells.  We are now studying these points.
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